Stocks · News reference

8-K filing — Cyclerion Therapeutics, Inc. (CYCN)

Aug 27, 2026, 10:01 AMSEC EDGAR

Filed: 2026-08-27 AccNo: 0001193125-26-369426 Size: 202 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CYCN

Source: edgar
Observed: Aug 27, 2026, 10:01 AM
Checked: Aug 27, 2026, 10:01 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 25, 2026, 8:18 PMBenzinga News-desk
Cyclerion Therapeutics Announces September 4 Record Date For Contingent Value Rights Distribution To Common And Series A Preferred Holders In Connection With Planned Korsana Biosciences Merger
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001755237/000119312526365150/d376250d8k.htm
Read original at benzinga
CYCN

8-K filing — Cyclerion Therapeutics, Inc. (CYCN)

Connected markets

Related headlines

Cyclerion Therapeutics Announces September 4 Record Date For Contingent Value Rights Distribution To Common And Series A Preferred Holders In Connection With Planned Korsana Biosciences Merger